EuBiologics Co

EuBiologics Co EBIT per Share

The EBIT per Share of EuBiologics Co (206650.KQ) as of Nov 2, 2026 is 1,656.37 KRW. In the previous year, EBIT per Share was 704.92 KRW — a change of 134.97% (higher).

EBIT per Share

1,656.37KRW

YoY

134.97%

Last updated:

EBIT per Share of EuBiologics Co is 2025 1,656.37 KRW. EBIT per Share of EuBiologics Co was 2024 704.92 KRW. It decreases by 134.97% higher compared to the previous year.

The EuBiologics Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-205.59 KRW
Jan 1, 2021
-199.30 KRW
Jan 1, 2022
-126.59 KRW
Jan 1, 2024
704.92 KRW
Jan 1, 2025
1,656.37 KRW
Jan 1, 2026 (e)
1,385.99 KRW
Jan 1, 2027 (e)
1,458.34 KRW
Jan 1, 2028 (e)
1,618.29 KRW
The EuBiologics Co EBIT per Share history
YEAREBIT per ShareYoY
est1,618.29KRW+10.97%
est1,458.34KRW+5.22%
est1,385.99KRW-16.32%
1,656.37KRW+134.97%
704.92KRW-656.84%
-126.59KRW-36.48%
-199.30KRW-3.06%
-205.59KRW-156.59%
363.30KRW+77.82%
204.31KRW-217.47%
-173.92KRW-57.24%
-406.71KRW+19.53%
-340.25KRW+86.85%
-182.10KRW-2.03%
-185.88KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EuBiologics Co Stock analysis

What does EuBiologics Co do? EuBiologics Co Ltd, headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company develops and manufactures biopharmaceutical products, with operations divided into two segments: the Vaccine segment, focusing on oral cholera vaccines, and the Contract Research and Manufacturing Organization (CRMO) segment, providing research and manufacturing services for biopharmaceuticals. Listed on January 24, 2017, EuBiologics employs 323 people. EuBiologics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EuBiologics Co stock

EBIT per Share of EuBiologics Co is 1,656.37 KRW in 2025.

EBIT per Share of EuBiologics Co changed from 704.92 KRW to 1,656.37 KRW, representing a 134.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share EuBiologics Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — EuBiologics Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — EuBiologics Co